Nasdaq

Channel Therapeutics Corporation Announces 10-for-1 Reverse Stock Split in Preparation for Merger and NYSE American Listing

Channel Therapeutics Corporation announces a 10-for-one reverse stock split to increase share price and meet NYSE American listing requirements. Channel Therapeutics Corporation announced a 10-for-one ...
Nasdaq

Channel Therapeutics Announces Reverse Common Stock Split in Conjunction with the Close of the Merger with Pelthos Therapeutics and Concurrent $50.1 Million Private Placement

FREEHOLD, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), an emerging leader in the development of non-opioid pain ...
Benzinga.com

Why Is Channel Therapeutics Stock Surging On Friday?

Channel Therapeutics announces 10-for-1 stock split ahead of merger. Company to rebrand as Pelthos Therapeutics and change ticker to PTHS. The next correction is closer than you think. Find out how ...